Fundraising Fox

Nippon Venture Capital

Venture capital

Tokyo · Pre-Seed–Late Stage

Also known as 日本ベンチャーキャピタル株式会社

Fox Verdict
Sign up to see your fit

Investment thesis

NVCC positions itself as a support-driven venture capital firm, founded by successful entrepreneurs and enthusiastic large corporations. It aims to back Japan's next generation of entrepreneurs and startups from a neutral standpoint, offering multifaceted assistance drawing on the experience of seasoned business operators across various fields.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Late Stage
Check
$1.5M – $269M
HQ
Tokyo, JP
Instruments
Equity
Founded
1996
Last 12 months
1 investment
AUM
$700M
Tracked investments
226

What they invest in

from 107 of 226 portfolio companies

Biotech ×26Healthtech ×22Medical Devices ×20AI & Machine Learning ×18SaaS ×18Enterprise Software ×13Deep Tech ×11Advanced Manufacturing ×9

HQs:Japan×105United States×1

Who they back

founder profiles across 34 portfolio companies
79%
solo founders
27 of 34 mapped founding teams

Founding team size:solo founder×272 founders×43 founders×24+ founders×1

Investments · 226 tracked

founders shown can be your intro path
InterCure Ltd.intercure.co.ilNASDAQ: INCRJun 2026

BiotechHertzliya

Alexander Rabinovich(Executive Officer, Director)David Salton(Director)Lennie Michelson Grinbaum(Director)Gideon Hirschfeld(Director)Amos Cohen(Chief Financial Officer)

MediciNova, Inc.medicinova.comNASDAQ: MNOV

Co-investorsEssex Woodlands Healthcare Partners

A-SEEDSa-seeds.co.jp

A-SEEDS is a Shinshu University spin-out developing non-viral gene-modified immune cell therapies, including non-viral CAR-T cell products, to treat pediatric and young-adult cancers, including solid tumors, that lack effective treatments.

BiotechDeep TechHealthtechMedical DevicesMatsumoto, JP

Yozo Nakazawa(Founder & Director; Professor, Department of Pediatrics, Shinshu University)Shigeki Yagyu(Representative Director (CEO))Takuji Achiha(Chief Development Officer)Kiyohito Tani(Chief Operating Officer)

Co-investorsDelight VenturesOSAKA University Venture Capital

Acucela Inc.acucela.com

Kubota Vision develops pharmaceutical drugs and medical devices to preserve and restore vision for patients with eye diseases worldwide.

BiotechMedical Devices

Aibrainscience
Aiロボティクス株式会社ai-robotics.co.jp

AI Robotics develops an AI system called "SELL" to analyze and optimize operations for direct-to-consumer (D2C) brands, covering product development, marketing, customer service, logistics, warehouse inventory management, and CRM.

AI & Machine LearningConsumerDirect to ConsumerTokyo, JP

ANYCOLOR株式会社anycolor.co.jp𝕏

ANYCOLOR is a Japanese entertainment startup that runs the VTuber / virtual livestreamer group "Nijisanji," along with overseas VTuber operations and new ventures.

Creator EconomyGamingMedia & EntertainmentTokyo, JP

田角 陸(代表取締役 CEO)釣井 慎也(取締役 CFO)

Co-investorsSkyland Ventures

AOI Biosciences株式会社aoibio.com

AOI Biosciences is a Japanese biotech company focused on infectious diseases and autoimmune disorders, combining data analysis technology with proprietary bio-technology.

BiotechHealthtechMedical DevicesIbaraki, JP

末田 伸一(代表取締役 (Representative Director/CEO))

Co-investorsi-nest capitalNOW JapanSeiho Investment WorksUntroD Capital

Aoibio
Arsaga Partners
Audiostock
Axelspace Holdingsaxelspacehd.comin𝕏

Axelspace provides microsatellite services through its "AxelLiner" one-stop offering — covering design, manufacturing, launch arrangement, and post-launch operation — and operates the "AxelGlobe" Earth observation platform built on its GRUS satellite constellation.

Deep TechHardwareSpace TechTokyo, JP

Yuya Nakamura(President and CEO)

Co-investorsJIC Venture Growth InvestmentsSMBC Venture Capital

Axelspacehd
Benners
Bplats, Inc.bplats.co.jp

Bplats operates Bplats®, a subscription management and billing platform for businesses.

Enterprise SoftwareFintechSaaS

Tack Miyazaki(Director, Vice President & CIO (Co-Founder))Kenji Fujita(Founder)inJunichi Ito(Director, Vice President & CFO)Shoichi Hanawa(Director & CTO)

Co-investorsGlobis Capital Partners

Chordia Therapeuticschordiatherapeutics.com

Cancer therapeutics development (RNA regulation abnormalities).

Co-investorsKyoto University Innovation CapitalShinsei Capital PartnersSMBC Venture CapitalUTokyo Innovation Platform Co. Ltd.

Contrea株式会社contrea.jp

Co-investorsCoral CapitalGlobal Brain

Creattura
Cyfuse Biomedicalcyfusebio.com

Cyfuse Biomedical develops a platform technology that builds three-dimensional tissues and organs from spheroids using its proprietary Bio 3D Printer.

BiotechHealthtechMedical Devices

Co-investorsDBJ CapitalSMBC Venture Capital

CynosBio株式会社cynosbio.com

CynosBio develops regenerative medicine products from academic and proprietary research, handling all stages from manufacturing to commercialization.

BiotechHealthtechMedical Devices

Delta-Fly Pharma株式会社delta-flypharma.co.jp

Co-investorsSMBC Venture Capital

Emostyle
Enecoat
Enerbank
Fivot AIを活用した融資審査モデルで成長企業を支援し、新しい金融エコシステムを構築。fivot.co.jp

Fivot provides financial services for both businesses and individuals, offering lending products aimed at supporting startup growth and savings services that help individuals save money toward their goals.

FintechTokyo, JP

Shogo Abe(代表取締役 (Representative Director / CEO))

Co-investorsAngel Bridge Co.,Ltd.Canal VenturesSony Ventures CorporationSpiral CapitalSpiral Innovation Partners

Gecipe
Gecs
GMO Payment Gateway, Inc.gmo-pg.com

Co-investorsGMO Internet

Hepalys
Kimitomirai
Kuzen
Lpixel
Metagen Therapeutics
Movus Technologies
movus technologies株式会社mo-vus.com

Co-investorsGenesia Ventures

Neusignal Therapeutics株式会社neusignal-tx.com

Neusignal Therapeutics develops novel drugs for central nervous system disorders, including dementia and psychiatric conditions, with research focused on calcium signaling in neurons and target discovery for brain diseases.

BiotechDeep TechDigital HealthMedical DevicesTokyo, JP

有本 達(代表取締役 (Representative Director/CEO))

Co-investorsAngel Bridge Co.,Ltd.Red CapitalFast Track InitiativeKeio Innovation InitiativeThe Gogin Capital

note株式会社note.jp𝕏

note is a media platform that lets creators publish and monetize text, images, audio, and other content, supporting a range of creative activities.

Creator EconomyMedia & EntertainmentSocial

Co-investorsFemto PartnersJAFCO GroupSMBC Venture CapitalTBS Innovation Partners

NYLE 2023nyle.co.jpin𝕏

Nyle is a Japanese company providing digital marketing services—including SEO and content marketing—alongside app-related products and AI training programs such as its practice-focused "With AI Academy".

AI & Machine LearningMarketing TechMedia & EntertainmentSaaS

Takahashi(Representative (CEO))

Co-investorsDIMENSIONEnergy & Environment Investment

Original Life
Perseus Proteomicsppmx.com

Perseus Proteomics (PPMX) is a Japanese biotech company that uses proprietary antibody technology to develop new antibody-based drugs.

BiotechDeep TechHealthtech

Co-investorsDBJ CapitalKyoto University Innovation CapitalNewton BiocapitalSMBC Venture Capital

Pharmabio
PRONI株式会社proni.co.jp𝕏

PRONI operates a concierge-style B2B matching service that connects buyers with suitable vendors, combining IT technology with human support to simplify procurement decisions such as research, comparison, and quoting.

B2B MarketplacesEnterprise SoftwareSaaSTokyo, JP

Norio Kuriyama(代表取締役 Founder)Daisuke Shibata(代表取締役 CEO)

Co-investorsFIRSTLIGHT CapitalJapan Post Capital Co. Ltd.JIC Venture Growth InvestmentsMobile Internet Capital, Inc.

Recovery International 株式会社recovery-group.co.jp

Recovery Group operates a home nursing care service in Japan, providing visiting nursing support to patients in their own homes as part of Japan's home medical care sector.

Digital HealthHealthtech

Regenephro
ReNet 2016renet.jp𝕏

Renet Japan operates a mail-based computer and small electronics recycling service authorized by the Japanese government under the Small Appliances Recycling Law.

Circular EconomyLogistics & Supply Chain

Co-investorsDIMENSION

RENOVA 2017renovainc.comin

Renova, Inc. (株式会社レノバ) is a Japanese company.

CleantechEnergy

Co-investorsDIMENSIONEnergy & Environment Investment

Restore Visionrestore-vis.comin

Restore Vis is a life sciences company founded by a vitreoretinal surgeon and clinician scientist focused on addressing inflammation, aging, neurodegeneration and angiogenesis through translational research from drug discovery to clinical trials.

BiotechDigital HealthHealthtechMedical DevicesTokyo, JP

Dr. Rajendra S. Apte(Paul A. Cibis Distinguished Professor; Vice Chair of Innovation and Translation; Founder)

Co-investorsAstellas Venture Management LLCDBJ CapitalJIC Venture Growth InvestmentsKyoto University Innovation CapitalOSAKA University Venture CapitalRemiges Ventures, Inc.+3 more

RYDE株式会社ryde-inc.jp𝕏

RYDE provides a mobile app for purchasing digital transit tickets across trains, buses, and shared mobility services in Japan.

Mobility & TransportationSaaSTokyo, JP

Securenavi
SOFTBRAIN Co., Ltd.softbrain.co.jp

Softbrain develops CRM/SFA (Customer Relationship Management/Sales Force Automation) software, specifically its flagship product esm (eSalesManager), which helps businesses improve sales productivity and customer engagement.

Enterprise SoftwareSaaSSales TechTokyo, JP

Co-investorsMITSUI & CO., Principal InvestmentsPolaris Capital Group

Space BDspace-bd.com𝕏

Space BD provides end-to-end support for space business, including satellite development and manufacturing, launch and deployment, on-orbit demonstration, and ground transport support.

Deep TechEdTechSpace Tech

Co-investorsAozora Corporate InvestmentHulic StartupON&BOARDSpiral CapitalSpiral Innovation PartnersXTech Ventures

STARFLYER 2011starflyer.jp

Co-investorsDIMENSION

Survbiopharma
SymBio Pharmaceuticalssymbiopharma.com

SymBio Pharmaceuticals develops and delivers prescription pharmaceuticals, providing product information on its medical drugs to healthcare professionals in Japan.

BiotechHealthtech

Co-investorsDBJ CapitalSMBC Venture CapitalTNP Partners Corporation

Tecdoctor
THECOO株式会社thecoo.co.jp

THECOO operates Fanicon, a subscription-based fan community app that lets creators ("icons") interact with fans through in-app live streaming, group chats, and messaging, along with paid features like point-based scratch lotteries.

ConsumerCreator EconomySocial

Co-investorsi-nest capitalZ Venture Capital

Transferdata
Tribeau

Browse all 226 investments with full details →

26 more tracked companies

株式会社モダリス株式会社ヨシムラ・フード・ホールディングス株式会社ラクーンホールディングス株式会社リアルビジョン株式会社リボミック株式会社レイ株式会社レイコフ株式会社レントラックジャパン株式会社ワコム株式会社ワッツ株式会社中村超硬株式会社交換できるくん株式会社京王ズ株式会社大泉製作所株式会社成学社株式会社東京ファイナンシャルプランナーズ株式会社松屋アールアンドディ株式会社省電舎株式会社総合医科学研究所株式会社翻訳センター株式会社薬王堂株式会社鷹山流通環境・エネルギー製造金融

Exits · 2

IPOs and acquisitions across the tracked portfolio

InterCure Ltd.NASDAQ: INCRMediciNova, Inc.NASDAQ: MNOV

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Nippon Venture Capital made?
Nippon Venture Capital has 226 tracked investments, including 1 dated in the last 24 months.
What stage does Nippon Venture Capital invest at?
Nippon Venture Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is Nippon Venture Capital's typical check size?
Nippon Venture Capital typically writes checks of $1.5M – $269M.
What sectors does Nippon Venture Capital focus on?
Nippon Venture Capital focuses on Biotech, Cleantech, Data & Infrastructure, EdTech, Hardware, Healthtech, Medical Devices, SaaS, Sector Agnostic.
Where is Nippon Venture Capital located?
Nippon Venture Capital is headquartered in Tokyo, JP.
Who does Nippon Venture Capital co-invest with?
Nippon Venture Capital most often shares deals with SMBC Venture Capital, DBJ Capital, Global Brain, among 76 tracked co-investors.

Similar investors

Featured in lists